Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evidence for Expanding the Role of Streptomycin in the Management of Drug-Resistant Mycobacterium tuberculosis.

Antimicrobial agents and chemotherapy - 20 Aug 2020

Cohen Keira A, Stott Katharine E, Munsamy Vanisha, Manson Abigail L, Earl Ashlee M, Pym Alexander S

Abstract excerpt

In 2019, the WHO tuberculosis (TB) treatment guidelines were updated to recommend only limited use of streptomycin, in favor of newer agents or amikacin as the preferred aminoglycoside for drug-resistant Mycobacterium tuberculosis However, the emergence of resistance to newer drugs, such as bedaquiline, has prompted a reanalysis of antitubercular drugs in search of untapped potential. Using 211 clinical isolates...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Drug Resistance, Multiple, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Microbial Sensitivity Tests

Share to Mycobacterium tuberculosis

Share to Pharmaceutical Preparations

Share to South Africa

Share to Streptomycin

Share to Tuberculosis, Multidrug-Resistant

Source

Open in PubMed Open full text

Identifiers

PMID: 32540971
DOI: 10.1128/AAC.00860-20
PMCID: PMC7449167

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evidence for Expanding the Role of Streptomycin in the Management of Drug-Resistant Mycobacterium tuberculosis.PMID 32540971Read ↗

Key resistance-associated mutations in multidrug-resistant tuberculosis: a genomic study from Shanghai, China, with a focus on aminoglycosides.Semantic proximity Read ↗

The Neglected Contribution of Streptomycin to the Tuberculosis Drug Resistance Problem.Semantic proximity Read ↗

Linking minimum inhibitory concentrations to whole genome sequence-predicted drug resistance in Mycobacterium tuberculosis strains from Romania.Semantic proximity Read ↗

Drug-Resistant Tuberculosis: A Glance at Progress and Global Challenges.Semantic proximity Read ↗

Drug-Resistant Tuberculosis 2020: Where We StandSemantic proximity Read ↗

Exploring diagnostic methods for drug-resistant tuberculosis: A comprehensive overview.Semantic proximity Read ↗

Mutations in gidB confer low-level streptomycin resistance in Mycobacterium tuberculosis.Semantic proximity Read ↗

Exploring Diagnostic Methods for Drug-Resistant Tuberculosis: A Comprehensive OverviewSemantic proximity Read ↗

Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives.Semantic proximity Read ↗

Global mapping of bedaquiline-resistant Mycobacterium tuberculosis: a systematic review.Semantic proximity Read ↗

Investigating resistance in clinical Mycobacterium tuberculosis complex isolates with genomic and phenotypic antimicrobial susceptibility testing: a multicentre observational study.Semantic proximity Read ↗

Multidrug-resistant tuberculosis: a comprehensive review of pathogenesis, drug resistance, current treatment and future prospects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.